1. Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients. Issue 2 (19th April 2021) Authors: Neerincx, Anne H.; Whiteson, Katrine; Phan, Joann L.; Brinkman, Paul; Abdel-Aziz, Mahmoud I.; Weersink, Els J.M.; Altenburg, Josje; Majoor, Christof J.; Maitland-van der Zee, Anke H.; Bos, Lieuwe D.J. Journal: ERJ open research Issue: Volume 7:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗